Nature Search

Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

Edward Seung
Zhen Xing
Gary J. Nabel
Amendments and Corrections24 Mar 2022
Nature

Volume: 604, P: E13
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

A trispecific antibody targeting HER2 and T cells stimulates CD4 T cell-dependent inhibition of of breast cancer cell proliferation in vitro and tumor regression in a humanized mouse model.

Edward Seung
Zhen Xing
Gary J. Nabel
Research23 Feb 2022
Nature

Volume: 603, P: 328-334
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

Kirill V. Kalnin
Timothy Plitnik
Danilo Casimiro
ResearchOpen Access19 Apr 2021
npj Vaccines

Volume: 6, P: 1-12
CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria

Kuldeep Singh
Cathleen S. Cornell
Sirkka Kyostio-Moore
ResearchOpen Access31 Mar 2021
Scientific Reports

Volume: 11, P: 1-14
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy

Loren W Noblitt
Dinesh S Bangari
Suresh K Mittal
Research15 Oct 2004
Cancer Gene Therapy

Volume: 12, P: 46-53
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

Berry, Pavot et al. test a vaccine with sequences of the spike protein of the Beta and ancestral variants to overcome immune escape by new SARS-CoV-2 variants. They show in animal models the vaccine successfully expands the breadth and duration of antibody neutralization of several variants and offers protection to some variants.

Catherine Berry
Vincent Pavot
Valerie Lecouturier
ResearchOpen Access26 May 2023
Communications Medicine

Volume: 3, P: 1-16
Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria

Rachna Manek
Yao V. Zhang
Sirkka R. M. Kyostio-Moore
ResearchOpen Access24 Nov 2021
Scientific Reports

Volume: 11, P: 1-13
Skeletal Characterization of the Fgfr3 Mouse Model of Achondroplasia Using Micro-CT and MRI Volumetric Imaging

Mohammed Salman Shazeeb
Megan K. Cox
Yves Sabbagh
ResearchOpen Access11 Jan 2018
Scientific Reports

Volume: 8, P: 1-13
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1

Loren W Noblitt
Dinesh S Bangari
Suresh K Mittal
Research10 Sept 2004
Cancer Gene Therapy

Volume: 11, P: 757-766

Search

Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria

Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria

Skeletal Characterization of the Fgfr3 Mouse Model of Achondroplasia Using Micro-CT and MRI Volumetric Imaging

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1

Search

Quick links

Search

Filter By:

Search

Quick links